test

Alexandra Fulk

@Sands Capital Ventures, Llc

Latest period2024 - Q3ReportedManaged Assets$355.771MTotal holdings20
Assets growth rate19.16%Assets growth rate (2-Q avg)-4.41%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Sands Capital Ventures, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 20 positions.

Assets under management

The assets under management (AUM) of Sands Capital Ventures, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 355.771M in assets, with a quarterly growth rate of 19.16% and a 2-quarter average growth rate of -4.41%. The portfolio is managed by Alexandra Fulk, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
KVYOKlaviyo Inc
Recent Activity
Decreased -0.02%
34.96%
$124.372M
3.515M shares@ $35.39 avg price
NUNu Hldgs Ltd
Recent Activity
Decreased -24.96%
21.1%
$75.059M
5.499M shares@ $13.65 avg price
DASHDoordash Inc
Recent Activity
Increased 0.06%
16.99%
$60.423M
423,338 shares@ $142.74 avg price
BIOABioage Labs Inc
Recent Activity
New Position
6.36%
$22.596M
1.086M shares@ $20.8 avg price
ACRVAcrivon Therapeutics Inc
Recent Activity
4.18%
$14.858M
2.123M shares@ $7.0 avg price
PATHUipath Inc
Recent Activity
4.16%
$14.787M
1.155M shares@ $12.81 avg price
SNOWSnowflake Inc
Recent Activity
3.5%
$12.44M
108,304 shares@ $114.86 avg price
TXG10x Genomics Inc
Recent Activity
3.06%
$10.878M
481,770 shares@ $22.59 avg price
ABOSAcumen Pharmaceuticals Inc
Recent Activity
2.39%
$8.474M
3.417M shares@ $2.48 avg price
TARSTarsus Pharmaceuticals Inc
Recent Activity
1.58%
$5.591M
170,000 shares@ $32.89 avg price